| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 九芝堂股份有限公司是中国著名老字号,综合经济实力在湖南省医药行业名列前茅,连续多年被评为"全国医药工业企业经济效益百强"和"湖南省工业企业经济效益百强".公司九芝堂制药厂丸剂生产线通过了中国药品监督管理局的GMP认证,同时工艺技术、装备水平、产品质量等已达到日本国厚生省药品标准.公司主要产品齐墩果酸片、肝立克、偏瘫灵、益龄精、斯奇康及浓缩丸系列产品,疗效确切、定位准确.多年来中成药浓缩丸系列产品、保健食品和植物提取物出口欧美,日本,东南亚等地区.其中十多种浓缩丸、片剂出口日本长达十五年之久,深受日本国民的信赖。完成借壳上市后，公司主营业务变更为从事中成药、生物药品的研制、生产、销售及药品的批发、零售业务及心脑血管疾病类药物的研发、生产和销售业务。 | ||||||||||||||||||||||||
| Main Business | 肝炎系列和补血系列中药的生产与销售；中药研发、生产和销售 | ||||||||||||||||||||||||
| Legal Representative | 孙光远 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 韩辰骁 | ||||||||||||||||||||||||
| Solicitors | 上海市锦天城律师事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙）;华普天健会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 010-84683155;0731-84499762 | ||||||||||||||||||||||||
| Fax No | 010-84682100;0731-84499759 | ||||||||||||||||||||||||
| Website | www.hnjzt.com | ||||||||||||||||||||||||
| hnjzt@hnjzt.com;dshbgs@hnjzt.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 28/06/2000 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.348 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.400 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 4.617 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 5.331B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |